ALZN vs. META

Last updated Aug 4, 2026

ALZN (Alzamend Neuro, Inc.) and META (Meta Platforms, Inc.) are both stocks. ALZN operates in Biotechnology (Healthcare), while META operates in Internet Content & Information (Communication Services). Over the past 5 years, ALZN returned -81.31%/yr vs 10.65%/yr for META. Their 0.17 correlation means their historical movements had little consistent relationship.

Performance

ALZN vs. META - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alzamend Neuro, Inc. (ALZN) and Meta Platforms, Inc. (META). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ALZN achieves a -26.37% return, which is significantly lower than META's -10.42% return.

ALZN

• 1D: 2.29%
• 1M: 15.52%
• 6M: -38.25%
• YTD: -26.37%
• 1Y: -39.09%
• 3Y*: -86.60%
• 5Y*: -81.31%
• 10Y*: —
• ALL TIME*: -86.51%

META

• 1D: 6.02%
• 1M: 1.26%
• 6M: -16.30%
• YTD: -10.42%
• 1Y: -21.04%
• 3Y*: 24.21%
• 5Y*: 10.65%
• 10Y*: 16.88%
• ALL TIME*: 20.51%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ALZN Alzamend Neuro, Inc.	$51.91K	$67.44K	$173.62K
META Meta Platforms, Inc.	$10.72B	$11.90B	$11.03B

ALZN vs. META - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ALZN Alzamend Neuro, Inc.	-26.37%	-82.57%	-86.97%	-89.50%	-70.27%	-93.45%
META Meta Platforms, Inc.	-10.42%	13.09%	66.05%	194.13%	-64.22%	-0.12%

Correlation

The correlation between ALZN and META is 0.11, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.11
Correlation (3Y) Balances recent behavior with more history.	0.08
Correlation (5Y) Shows whether the relationship held over a longer period.	0.16
Correlation (All Time) Calculated using the full available price history since Jun 15, 2021	0.17

Fundamentals

Market Cap ALZN : $5.10M META : $1.50T
EPS ALZN : -$1.96 META : $26.51
Total Revenue (TTM) ALZN : $0.00 META : $228.25B
Gross Profit (TTM) ALZN : $0.00 META : $186.59B
EBITDA (TTM) ALZN : -$6.94M META : $107.07B

Return for Risk

ALZN vs. META — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ALZN

ALZN Risk / Return Rank: 21
ALZN Sharpe Ratio Rank: 20
ALZN Sortino Ratio Rank: 23
ALZN Omega Ratio Rank: 23
ALZN Calmar Ratio Rank: 22
ALZN Martin Ratio Rank: 18

META

META Risk / Return Rank: 19
META Sharpe Ratio Rank: 19
META Sortino Ratio Rank: 19
META Omega Ratio Rank: 19
META Calmar Ratio Rank: 20
META Martin Ratio Rank: 17

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ALZN vs. META - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alzamend Neuro, Inc. (ALZN) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ALZN	META	Difference
Sharpe ratio: Return per unit of total volatility	-0.52	-0.55	+0.03
Sortino ratio: Return per unit of downside risk	-0.36	-0.59	+0.23
Omega ratio: Gain probability vs. loss probability	0.95	0.93	+0.03
Calmar ratio: Return relative to maximum drawdown	-0.58	-0.63	+0.05
Martin ratio: Return relative to average drawdown	-1.08	-1.15	+0.07

ALZN vs. META - Sharpe Ratio Comparison

The current ALZN Sharpe Ratio is -0.52, which is comparable to the META Sharpe Ratio of -0.55. The chart below compares the historical Sharpe Ratios of ALZN and META, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ALZN vs. META - Drawdown Comparison

The maximum ALZN drawdown since its inception was -100.00%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for ALZN and META.

Drawdown Indicators

	ALZN	META	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-76.74%	-23.26%
Max Drawdown (1Y) Largest decline over 1 year	-67.27%	-33.30%	-33.97%
Max Drawdown (3Y) Largest decline over 3 years	-99.85%	-34.15%	-65.70%
Max Drawdown (5Y) Largest decline over 5 years	-99.98%	-76.74%	-23.24%
Max Drawdown (10Y) Largest decline over 10 years	—	-76.74%	—
Current Drawdown Current decline from peak	-100.00%	-25.04%	-74.96%
Average Drawdown Average peak-to-trough decline	-97.57%	-15.90%	-81.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	36.12%	18.31%	+17.81%

Volatility

ALZN vs. META - Volatility Comparison

The current volatility for Alzamend Neuro, Inc. (ALZN) is 13.27%, while Meta Platforms, Inc. (META) has a volatility of 15.82%. This indicates that ALZN experiences smaller price fluctuations and is considered to be less risky than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ALZN	META	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.27%	15.82%	-2.55%
Volatility (6M) Calculated over the trailing 6-month period	66.19%	30.76%	+35.43%
Volatility (1Y) Calculated over the trailing 1-year period	75.66%	38.57%	+37.09%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	125.92%	44.77%	+81.15%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	128.79%	39.16%	+89.63%

Dividends

ALZN vs. META - Dividend Comparison

ALZN has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.36%.

Position	TTM	2025	2024
ALZN Alzamend Neuro, Inc.	0.00%	0.00%	0.00%
META Meta Platforms, Inc.	0.36%	0.32%	0.34%

Financials

Frequently Asked Questions

Can I hold both ALZN and META in my portfolio?

ALZN and META have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ALZN or META?

META has higher volatility (15.82%) compared to ALZN (13.27%). In terms of maximum drawdown, ALZN dropped -100.00% vs META's -76.74%.

Which has better risk-adjusted returns?

ALZN currently has the higher Sharpe Ratio (-0.52 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.